Ticker Scorecard - AKRO Basics Company: Akero Therapeutics, Inc. IPO Date: July 17, 2019 Sector: Healthcare Industry: Biotech Market Cap: $4.3B Activated in VL: True Average Daily Range Avg Daily Range: $0.74 | 2.88% Avg Daily Range (30 D): $1.01 | 2.92% Avg Daily Range (90 D): $0.84 | 2.64% Institutional Daily Volume Avg Daily Volume: .48M Avg Daily Volume (30 D): 1.42M Avg Daily Volume (90 D): .79M Trade Size Avg Trade Size (Sh.): 67 Avg Trade Size (Sh.) (30 D): 69 Avg Trade Size (Sh.) (90 D): 62 Institutional Trades Total Inst.Trades: 1,970 Avg Inst. Trade: $2.36M Avg Inst. Trade (30 D): $2.18M Avg Inst. Trade (90 D): $2.15M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.44M Avg Closing Trade (30 D): $5.46M Avg Closing Trade (90 D): $3.41M Avg Closing Volume: 114.87K     News Feb 2, 2025 @ 11:21 PM This Stock Just Doubled in 1 Day -- Is It Still a ... Source: Prosper Junior Bakiny Jan 29, 2025 @ 2:30 AM Akero Therapeutics Announces Pricing of Upsized Pu... Source: N/A Jan 27, 2025 @ 11:30 AM Akero Therapeutics Reports Preliminary Topline Res... Source: N/A Nov 15, 2024 @ 4:00 PM Akero Therapeutics to Showcase New Analyses of Pha... Source: N/A Oct 21, 2024 @ 11:00 AM Akero Therapeutics to Present Data Reinforcing the... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-3.78 $-1.05 $-.81 Diluted EPS $-3.77 $-1.05 $-.81 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -237.22M $ -72.71M $ -55.99M Operating Income / Loss $ -269.27M $ -81.7M $ -65.74M Cost of Revenue $ $ $ Net Cash Flow $ 46.52M $ 5.71M $ -313.5M PE Ratio